240 related articles for article (PubMed ID: 9631649)
21. Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).
Withoff S; De Jong S; De Vries EG; Mulder NH
Anticancer Res; 1996; 16(4A):1867-80. PubMed ID: 8712715
[TBL] [Abstract][Full Text] [Related]
22. Self-association and DNA binding properties of the human topoisomerase IIA alpha2HTH module.
Morant-Lhomel A; René B; Zargarian L; Troalen F; Mauffret O; Fermandjian S
Biochimie; 2006; 88(3-4):253-63. PubMed ID: 16213649
[TBL] [Abstract][Full Text] [Related]
23. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
Jain P; Nagaraja V
Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of type II topoisomerase in the endosymbiont-bearing Trypanosomatid Blastocrithidia culicis.
Lourenço EE; Cavalcanti DP; Assine Picchi GF; Souza W; Aurélio Krieger M; Machado Motta MC; Goldenberg S; Perdigão Fragoso S
FEMS Microbiol Lett; 2006 Apr; 257(1):163-70. PubMed ID: 16553848
[TBL] [Abstract][Full Text] [Related]
25. Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.
Mirski SE; Gerlach JH; Cole SP
Exp Cell Res; 1999 Sep; 251(2):329-39. PubMed ID: 10471318
[TBL] [Abstract][Full Text] [Related]
26. The identification and characterisation of a functional interaction between arginyl-tRNA-protein transferase and topoisomerase II.
Barker CR; Mouchel NA; Jenkins JR
Biochem Biophys Res Commun; 2006 Apr; 342(2):596-604. PubMed ID: 16488395
[TBL] [Abstract][Full Text] [Related]
27. A role of topoisomerase II in linking DNA replication to chromosome condensation.
Cuvier O; Hirano T
J Cell Biol; 2003 Mar; 160(5):645-55. PubMed ID: 12604590
[TBL] [Abstract][Full Text] [Related]
28. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
[TBL] [Abstract][Full Text] [Related]
29. Binding of etoposide to topoisomerase II in the absence of DNA: decreased affinity as a mechanism of drug resistance.
Kingma PS; Burden DA; Osheroff N
Biochemistry; 1999 Mar; 38(12):3457-61. PubMed ID: 10090731
[TBL] [Abstract][Full Text] [Related]
30. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
31. Structural homology between DNA binding sites of DNA polymerase beta and DNA topoisomerase II.
Mizushina Y; Sugawara F; Iida A; Sakaguchi K
J Mol Biol; 2000 Dec; 304(3):385-95. PubMed ID: 11090281
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the topoisomerase II-DNA cleavable complex by the ortho-quinone derivative of the antitumor drug etoposide (VP-16).
Gantchev TG; Hunting DJ
Biochem Biophys Res Commun; 1997 Aug; 237(1):24-7. PubMed ID: 9266822
[TBL] [Abstract][Full Text] [Related]
33. Random mutagenesis of the B'A' core domain of yeast DNA topoisomerase II and large-scale screens of mutants resistant to the anticancer drug etoposide.
Jiang X
Biochem Biophys Res Commun; 2005 Feb; 327(2):597-603. PubMed ID: 15629155
[TBL] [Abstract][Full Text] [Related]
34. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy.
Wang JC
NCI Monogr; 1987; (4):3-6. PubMed ID: 2819727
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells.
Sumner AT
Exp Cell Res; 1995 Apr; 217(2):440-7. PubMed ID: 7698244
[TBL] [Abstract][Full Text] [Related]
36. Molecular and cellular interactions between intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy.
Morjani H; Riou JF; Nabiev I; Lavelle F; Manfait M
Cancer Res; 1993 Oct; 53(20):4784-90. PubMed ID: 8402662
[TBL] [Abstract][Full Text] [Related]
37. Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms.
Huang PL; Chen HC; Kung HF; Huang PL; Huang P; Huang HI; Lee-Huang S
Biofactors; 1992 Dec; 4(1):37-41. PubMed ID: 1337969
[TBL] [Abstract][Full Text] [Related]
38. DNA topoisomerase IIβ: a player in regulation of gene expression and cell differentiation.
Vávrová A; Šimůnek T
Int J Biochem Cell Biol; 2012 Jun; 44(6):834-7. PubMed ID: 22465709
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of tobacco DNA topoisomerases II in cell cycle regulation: to manage topological constrains during replication, transcription and mitotic chromosome condensation and segregation.
Singh BN; Achary VMM; Panditi V; Sopory SK; Reddy MK
Plant Mol Biol; 2017 Aug; 94(6):595-607. PubMed ID: 28634865
[TBL] [Abstract][Full Text] [Related]
40. SARs on an 835 kb DNA fragment from the Drosophila genome.
Miassod R; Jullien N
Acta Biochim Pol; 1995; 42(2):161-70. PubMed ID: 8588458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
